Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standardizing the Definition of Each Colon Cancer Segment: Delphi Consensus on Clinical Decision-Making for Oncologic Outcomes.

Diseases of the colon and rectum·2025

Same author

Some is Better than None: Adjuvant Chemotherapy in Rectal Cancer After Pathologic Complete Response.

Annals of surgical oncology·2024

Same author

Splenic flexure adenocarcinoma: A national cohort analysis of extent of surgical resection and outcomes.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2024

Same author

The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.

Annals of surgical oncology·2024

Same author

A population-based analysis on the incidence of metachronous colon cancer after endoscopic resection of advanced adenomas with high-grade dysplasia: does location matter?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2024

Same author

Reply.

Diseases of the colon and rectum·2023

Search research articles

Related Experiment Video

Updated: Apr 17, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparative effectiveness in colon and rectal cancer.

Christine C Jensen¹, Robert D Madoff

¹University of Minnesota, Minneapolis, MN, USA, cjensen@crsal.org.

Cancer Treatment and Research

|February 14, 2015

Summary

Standardized guidelines are improving colorectal cancer care, but controversies remain. This review examines key debates in treatment, including surgical approaches for hereditary nonpolyposis colorectal cancer and metastatic disease.

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Related Experiment Videos

Last Updated: Apr 17, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Area of Science:

Oncology
Surgical Oncology
Gastroenterology

Background:

Colorectal cancer treatment is increasingly standardized.
Several controversial areas persist despite guideline adherence.

Purpose of the Study:

To examine controversial issues in colorectal cancer treatment.
To discuss potential resolutions for these clinical dilemmas.

Main Methods:

Review of current literature and clinical practice guidelines.
Analysis of specific controversial scenarios in colorectal cancer management.

Main Results:

Discussion of segmental vs. extended colectomy in hereditary nonpolyposis colorectal cancer.
Evaluation of primary tumor resection in unresectable metastatic colorectal cancer.
Assessment of extended lymph node resection and robotic vs. laparoscopic approaches.

Conclusions:

Addressing these controversies is crucial for optimizing colorectal cancer patient outcomes.
Further research and consensus are needed to clarify best practices in specific colorectal cancer scenarios.